Prediction of likelihood of cancer recurrence
Details for Australian Patent Application No. 2004283068 (hide)
International Classifications
Event Publications
2 February 2006 PCT application entered the National Phase
PCT publication WO2005/039382 Priority application(s): WO2005/039382
27 April 2006 Change of Name(s) of Applicant(s), Section 104
Genomic Health, Has no value - Entry Incomplete The name of the applicant has been changed to Genomic Health, Inc.
25 May 2006 Change of Name(s) of Applicant(s), Section 104
Genomic Health, Inc. The name of the applicant has been changed to Genomic Health, Inc.; NSABP Foundation, Inc.
3 December 2009 Amendment Made
The nature of the amendment is: Amend the priority details to add under INID (62) 2004205878; 2004213871
11 February 2010 Amendment Made
The nature of the amendment is: Amend the priority details to delete under INID (62) 2004205787 and 2004213871
18 March 2010 Application Accepted
Published as AU-B-2004283068
15 July 2010 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004283073-Treatment of inflammatory bowel disease with 2-methylene-19-nor-vitamin D compounds
2004283067-Transdermal high and low molecular weight compounds
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser